Freenome Holdings
Open enrollment across a mixed-phase pipeline
According to ClinicalTrials.gov-derived indexes, Freenome Holdings sits in the upper quartile of US sponsors by registered trial count (#2,411 of 15,742 sponsors by registered trial count).
Freenome Holdings: 5 sponsored US clinical trials, 1 recruiting.
Freenome Holdings sponsors 5 registered US clinical trials on ClinicalTrials.gov, 1 of them currently recruiting, and 4 completed. The most-studied condition in this pipeline is Lung Cancer (Diagnosis), with 1 trials.
Upper-quartile sponsor footprint
Freenome Holdings sits in the upper quartile of the sponsor corpus (#2,411 of 15,742 sponsors by registered trial count) - denser than most sponsors, still short of the top-decile hubs.
Open and recent trials
5 total, page 1 of 1
Clinical Validation of Freenome Multiomics Blood Test for Lung Cancer Screening
NCT06122077
The Sanderson Study: A Case Control Study for the Development of Multiomics Blood Tests for Cancer Screening
NCT05516927
The Vallania Study: A Case Control Study for the Development of Multiomics Blood Tests for Cancer Screening
NCT05254834
Prevention of Colorectal Cancer Through Multiomics Blood Testing
NCT04369053
AI-EMERGE: Development and Validation of a Multi-analyte, Blood-based Colorectal Cancer Screening Test
NCT03688906
Therapeutic Areas
What is open in the Freenome Holdings pipeline
1 recruiting of 5 indexed (20% open); 4 completed (80%).
Phase labels are sparse on this sponsor index, so phase mix is not charted here.
Top condition: Lung Cancer (Diagnosis) (1 trial), 1 other listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
Freenome Holdings: open-pipeline peers nationwide
Peers matched on 5 registered trials and 20% open enrollment, not the therapeutic-area sidebar.
Freenome Holdings sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 5 trials (± recruiting share)
- 4YouandMe · 5 trials · 0% recruiting
- Abbott Rapid Dx · 5 trials · 0% recruiting
- Access Business Group · 5 trials · 0% recruiting
- Acera Surgical · 5 trials · 20% recruiting
Sponsors near 20% open enrollment (± trial volume)
- Align Technology · 20% recruiting · 5 trials
- AltruBio · 20% recruiting · 5 trials
- Alvernia University · 20% recruiting · 5 trials
- Amazentis · 20% recruiting · 5 trials
Related
What to do with this Freenome Holdings page
5 registered trials is a research-attention snapshot, not an endorsement of Freenome Holdings or any single study.
- 1 of Freenome Holdings's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Lung Cancer (Diagnosis) is the condition Freenome Holdings studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Lung Cancer (Diagnosis) trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. Freenome Holdings pipeline card: 5 registered trials from official public datasets. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.